A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in over 100 low and middle-income countries at an affordable price of $40 per ...
To reflect this reality, the Gladstone Institute of Virology has taken on a new name: the Gladstone Infectious Disease ...
A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...
Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...
Globally, over half of people living with HIV are women. But in clinical cure trials, they make up only about 20% of ...
Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...
Close monitoring of HIV viral load is crucial to prevent LLV among HIV-positive patients on ART, particularly older adults with low CD4+ counts and a history of PI use.
AZoLifeSciences on MSN
Discovery of R-Loops Reveals Key Vulnerability in HIV-1 Life Cycle
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...
10d
How Mpox revealed an epidemic of untreated HIV in Sierra Leone – as Trump’s aid cuts begin to bite
The impact of the US slashing foreign aid on the country’s Mpox response has likely been huge, activists on the ground tell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback